Jaime Bosch

Active 1979–2025

260
Papers
52,756
Citations
127
h-index
250
i10-index

Citations

Citations per year for Jaime Bosch1980: 1 citations1981: 2 citations1983: 4 citations1984: 7 citations1985: 15 citations1986: 20 citations1987: 16 citations1988: 17 citations1989: 43 citations1990: 20 citations1991: 16 citations1992: 36 citations1993: 33 citations1994: 34 citations1995: 61 citations1996: 29 citations1997: 35 citations1998: 49 citations1999: 85 citations2000: 83 citations2001: 123 citations2002: 105 citations2003: 147 citations2004: 105 citations2005: 137 citations2006: 154 citations2007: 210 citations2008: 264 citations2009: 233 citations2010: 276 citations2011: 225 citations2012: 294 citations2013: 255 citations2014: 344 citations2015: 365 citations2016: 348 citations2017: 455 citations2018: 312 citations2019: 1,240 citations2020: 1,400 citations2021: 1,447 citations2022: 1,168 citations2023: 1,129 citations2024: 1,701 citations2025: 799 citations2026: 32 citations1982: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,318 citing papers, 18.6% of this breakdownChina: 1,174 citing papers, 9.4% of this breakdownSpain: 996 citing papers, 8% of this breakdownUnited Kingdom: 847 citing papers, 6.8% of this breakdownItaly: 818 citing papers, 6.6% of this breakdownGermany: 654 citing papers, 5.2% of this breakdownFrance: 580 citing papers, 4.7% of this breakdownCanada: 393 citing papers, 3.1% of this breakdownSwitzerland: 327 citing papers, 2.6% of this breakdownAustralia: 301 citing papers, 2.4% of this breakdownJapan: 295 citing papers, 2.4% of this breakdownAustria: 256 citing papers, 2.1% of this breakdown
0%18.6%Other 28.1%

Fields

  • Medicine81%
  • Biochemistry, Genetics and Molecular Biology7.1%
  • Environmental Science5.3%
  • Agricultural and Biological Sciences2.2%
  • Immunology and Microbiology1.9%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Other1.9%

Topics

  • Liver Disease and Transplantation17.4%
  • Liver Disease Diagnosis and Treatment17.2%
  • Organ Transplantation Techniques and Outcomes5.8%
  • Hepatocellular Carcinoma Treatment and Prognosis3.6%
  • Liver physiology and pathology3%
  • Liver Diseases and Immunity1.9%
  • Other51.1%

Coauthors

All papers

Open in search
  1. Baveno VII – Renewing consensus in portal hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jidong Jia, Jean‐Jacques Kiladjian, Aleksander Krag, Wim Laleman, Vincenzo La Mura, Sabela Lens, Xuefeng Luo, Mattias Mandorfer, Sarwa Darwish Murad, Valérie Paradis, David Patch, Salvatore Piano, Massimo Pinzani, Aurélie Plessier, Massimo Primignani, Bogdan Procopeț, Pierre‐Emmanuel Rautou, Marika Rudler, Shiv Kumar Sarin, Filippo Schepis, Marco Senzolo, Vijay H. Shah, Akash Shukla, Puneeta Tandon, Luís Téllez, Dominique Thabut, Maja Thiele, Jonel Trebicka, Dhiraj Tripathi, Emmanouil Tsochatzis, Laura Turco, Fanny Turón, Dominique Valla, Càndid Villanueva, Ian R. Wanless, Hitoshi Yoshiji - Journal of Hepatology 2021 cited by 2,669

  2. Portal hypertensive bleeding in cirrhosis

    Authors: , , , - Hepatology 2016 cited by 2,099

  3. Liver cirrhosis

    Authors: , , - The Lancet 2014 cited by 1,735

  4. AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis

    Authors: , , , , , , - Hepatology 2023 cited by 388

  5. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction

    Authors: , , , , - Journal of Hepatology 2021 cited by 393

  6. Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated Cirrhosis

    Authors: , , , , , , , , , , , - Gastroenterology 2007 cited by 1,175

  7. Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis

    Authors: , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2018 cited by 372

  8. The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials

    Authors: , , , , , , , , , , , , , , , , , , - Hepatology 2019 cited by 389

  9. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease

    Authors: , , , , , , , , , , , , , , , , , , , , - The American Journal of Gastroenterology 2020 cited by 243

  10. Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis

    Authors: , , , , , , , , , , , , , , , , , , , - Hepatology 2021 cited by 151

  11. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis

    Authors: , , , , , , , , , , , , , - Journal of Hepatology 2022 cited by 177

  12. Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Gut 2022 cited by 98

  13. The clinical use of HVPG measurements in chronic liver disease

    Authors: , , , - Nature Reviews Gastroenterology & Hepatology 2009 cited by 714

  14. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study

    Authors: , , , , , , , , , , - Hepatology 2016 cited by 376

  15. Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding

    Authors: , , , , , , , , , , - New England Journal of Medicine 2010 cited by 1,237

  16. Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease

    Authors: , , , , , , , , , , - Journal of Hepatology 2020 cited by 163

  17. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study

    Authors: , , , , , , , , , , , - Hepatology 2016 cited by 328

  18. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta‐analysis

    Authors: , , , , - Hepatology 2014 cited by 389

  19. Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated Cirrhosis

    Authors: , , , , , , , - Gastroenterology 2012 cited by 531

  20. Non-invasive tests for clinically significant portal hypertension after HCV cure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jaime Bosch, Juan Carlos García‐Pagán, Mattias Mandorfer - Journal of Hepatology 2022 cited by 84

  21. Management of Varices and Variceal Hemorrhage in Cirrhosis

    Authors: , - New England Journal of Medicine 2010 cited by 945

  22. Recent Asian origin of chytrid fungi causing global amphibian declines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sara Meurling, Claude Miaud, Pete Minting, Frank Pasmans, Dirk S. Schmeller, Benedikt R. Schmidt, Jennifer Shelton, Lee F. Skerratt, Freya Smith, Claudio Azat, Matteo Spagnoletti, Giulia Tessa, Luı́s Felipe Toledo, Andrés Valenzuela‐Sánchez, Ruhan Verster, Judit Vörös, Rebecca J. Webb, Claudia Wierzbicki, Emma Wombwell, Kelly R. Zamudio, David M. Aanensen, Timothy Y. James, M. Thomas P. Gilbert, Ché Weldon, Jaime Bosch, François Balloux, Trenton W. J. Garner, Matthew C. Fisher - Science 2018 cited by 599

  23. Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis

    Authors: , , , , , , , , , , - Hepatology 2011 cited by 314

  24. Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zeid Kayali, Nyingi Kemmer, Kevin Korenblat, Ming‐Zong Lai, Charles Landis, E.J. Lawitz, William M. Lee, Steven D. Lidofsky, Edward Mena, Mazen Noureddin, Angelo H. Paredes, Nikolaos Pyrsopoulos, K. Rajender Reddy, M. Rinella, Don C. Rockey, Manuel Rodríguez, Michele B. Ryan, Souvik Sarkar, Sanjaya K. Satapathy, Andrew Scanga, Mitchell L. Shiffman, Mohammad Shadab Siddiqui, Douglas A. Simonetto, Wing‐Kin Syn, Paul J. Thuluvath, Ramesh Vemulapalli, John M. Vierling, Ziad Younes, Agustı́n Albillos, Juan Arenas Ruiz-Tapiador, Salvador Augustín, José Luís Calleja, J. Crespo Garcia, L. García Buey, Juan Carlos García‐Pagán, Càndid Villanueva, C. Bureau, N. Carbonell, Valériane Leroy, Pierre‐Emmanuel Rautou, HS Heinzow, Ingolf Schiefke, Alexander Zipprich, Annalisa Berzigotti, Beat Muellhaupt - Journal of Hepatology 2019 cited by 156